1981
DOI: 10.1128/iai.33.1.231-238.1981
|View full text |Cite
|
Sign up to set email alerts
|

Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus

Abstract: Immunoglobulin-containing cells were revealed by immunofluorescence in lung sections from mice infected with influenza virus by the aerosol route. The numbers of immunoglobulin A (IgA)and IgM-containing cells were increasing by day 3 of the infection, whereas IgG-containing cells appeared a few days later. The responding B-cell populations appeared in two principal locations: along major airways and in consolidated lesions within lung parenchyma. IgA-containing cells were the most numerous isotype, occurring p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

1984
1984
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(3 citation statements)
references
References 21 publications
1
2
0
Order By: Relevance
“…After VA administration, a change in cell population distribution was found. Changes in cell population were also noted by others following IN administration of influenza [Owens et al, 1981;Scott and Walker, 1976;Wyde and Cate, 19781. The CMI response following IN application preceded local or humoral antibody response in the case of VA, as found by others [Wells et al, 19791, and was also induced by VF preparation; nevertheless, VF failed to induce local antibody response against the two surface glycoproteins, hemagglutinin and neuraminidase. Lack of local secretory antibodies following local application of VF was corroborated by the failure of such preparations to induce augmentation in the number of B surface IgAbearing lymphocytes, in contrast to the increased percentage of this cell type following immunization with VA.…”
Section: Discussionsupporting
confidence: 54%
“…After VA administration, a change in cell population distribution was found. Changes in cell population were also noted by others following IN administration of influenza [Owens et al, 1981;Scott and Walker, 1976;Wyde and Cate, 19781. The CMI response following IN application preceded local or humoral antibody response in the case of VA, as found by others [Wells et al, 19791, and was also induced by VF preparation; nevertheless, VF failed to induce local antibody response against the two surface glycoproteins, hemagglutinin and neuraminidase. Lack of local secretory antibodies following local application of VF was corroborated by the failure of such preparations to induce augmentation in the number of B surface IgAbearing lymphocytes, in contrast to the increased percentage of this cell type following immunization with VA.…”
Section: Discussionsupporting
confidence: 54%
“…B cells comprise only a very small proportion of the mononuclear cells early in the viral inflammatory process, but, like macrophages, increase in later phases. B cells have been shown to appear late in the inflammatory response to poliomyelitis in humans (36), influenza pneumonia in mice (37), and the autoimmune demyelinating disease, experimental allergic encephalomyelitis (38,39). It is likely that B cells, like monocytes, also enter local inflammatory reactions in response to lymphokines produced by T cells of the Lyt-1 phenotype already present at the site of antigenic stimulation in the CNS (34).…”
Section: Discussionmentioning
confidence: 99%
“…It is relatively small when measured as free antibody in serum but substantial when measured as ASC response in draining lymph nodes (28). Finally, although the therapeutic activities of mAb were determined by treatment of mice 1 day after infection (to reduce the likelihood of outgrowth of viral escape mutants), extensive pulmonary infections can be cured with polyspecific mixtures of iTiAh (48), Interestingly, delayed treatment does not require much larger antibody doses than early treatment, prestmiably because u-ansudation is greatly increased by the inflammatory process at this stage (56).…”
Section: Therapeutic Activities Of Passive Antibodies In Scid Micementioning
confidence: 99%